RAF1 and neoplasm: Endothelial cells and pericytes' vascular endothelial growth factor receptors (VEGFR) and platelet-derived growth factor receptors (PDGFR) can be targeted for reducing angiogenesis, whereas tumor cells' B-RAF and RAF1 can be inhibited to reduce cell proliferation.